Select Vaccines partner ships hep E kits to hotspot
Wednesday, 08 September, 2004
Select Vaccines' (ASX:SLT) licence partner Genelabs Diagnostics has provided the World Health Organisation with a "significant quantity" of the hepatitis E rapid diagnostic kits developed by Select, the company said today.
The kits, which were provided to the WHO on a humanitarian basis, will be used in the Darfur region of Sudan to help contain an outbreak of hepatitis E in the refugee camps. Select Vaccines licensed the hepatitis E rapid diagnostic kit, as well as a laboratory diagnostic to Genelabs for a 12-year term in August, in return for upfront payments and royalties.
Bird flu found in Victorian egg farm, returned traveller
Two separate instances of avian influenza (bird flu) were reported in Victoria yesterday —...
Cell-mapping project to uncover genetic fingerprints of disease
The $27m project will see researchers map 50 million human cells from 10,000 people to identify...
People with autism appear predisposed to PTSD
While recent studies in humans have highlighted the co-occurrence of ASD and PTSD, the link...